This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smith, D J Articles by Eastcott, J Search for Related Content PubMed PubMed Citation Articles by Smith, D J Articles by Eastcott, J

research-article

Immunological characteristics of a synthetic peptide associated with a catalytic domain of mutans streptococcal glucosyltransferase.

Department of Immunology, Forsyth Dental Center, Boston, Massachusetts 02115.

ABSTRACT

The immunogenicity of a multiple antigenic peptide construct consisting of four copies of the synthetic 21-mer peptide DANFDSIRVDAVDNVDADLLQ was measured. The composition of this peptide was derived from a sequence in the N-terminal region of mutans streptococcal glucosyltransferases (GTFs) containing an aspartic acid implicated in catalysis. The peptide (CAT) construct was synthesized as a tetramer on a lysine backbone and subcutaneously injected into Sprague-Dawley rats for polyclonal antibody formation or intraperitoneally injected into BALB/c mice, and then spleen cell fused with Sp2/0Ag14 murine myeloma cells for monoclonal antibody formation. The resulting rat antisera and mouse monoclonal antibodies reacted with CAT and with native GTF isozymes from Streptococcus sobrinus and Streptococcus mutans (in enzyme-linked immunosorbent assay and Western blot [immunoblot] analyses). Functional inhibition of the water-insoluble glucan synthetic activity of S. sobrinus GTF-I was demonstrated with an immunoglobulin M anti-CAT monoclonal antibody (> 80% inhibited) and with rat sera (approximately 17% inhibited). The monoclonal antibody preparation also modestly inhibited the water-soluble glucan synthetic activity of an S. mutans GTF mixture. These results suggest that the CAT peptide contains B-cell epitopes that are similar to those of intact mutans streptococcal GTFs and has the potential to elicit antibody that can inhibit GTF function. Thus, sequences within this peptide construct may have value for inclusion in a synthetic dental caries vaccine.

This article has been cited by other articles:

• Culshaw, S., LaRosa, K., Tolani, H., Han, X., Eastcott, J. W., Smith, D. J., Taubman, M. A. (2007). Immunogenic and Protective Potential of Mutans Streptococcal Glucosyltransferase Peptide Constructs Selected by Major Histocompatibility Complex Class II Allele Binding. Infect. Immun. 75: 915-923 [Abstract] [Full Text]  
• Smith, D. J., King, W. F., Rivero, J., Taubman, M. A. (2005). Immunological and Protective Effects of Diepitopic Subunit Dental Caries Vaccines. Infect. Immun. 73: 2797-2804 [Abstract] [Full Text]  
• Mattos-Graner, R. O., Napimoga, M. H., Fukushima, K., Duncan, M. J., Smith, D. J. (2004). Comparative Analysis of Gtf Isozyme Production and Diversity in Isolates of Streptococcus mutans with Different Biofilm Growth Phenotypes. J. Clin. Microbiol. 42: 4586-4592 [Abstract] [Full Text]  
• Guo, J.H., Jia, R., Fan, M.W., Bian, Z., Chen, Z., Peng, B. (2004). Construction and Immunogenic Characterization of a Fusion Anti-caries DNA Vaccine against PAc and Glucosyltransferase I of Streptococcus mutans. J. Dent. Res. 83: 266-270 [Abstract] [Full Text]  
• Zhang, P., Jespersgaard, C., Lamberty-Mallory, L., Katz, J., Huang, Y., Hajishengallis, G., Michalek, S. M. (2002). Enhanced Immunogenicity of a Genetic Chimeric Protein Consisting of Two Virulence Antigens of Streptococcus mutans and Protection against Infection. Infect. Immun. 70: 6779-6787 [Abstract] [Full Text]  
• Smith, D.J. (2002). DENTAL CARIES VACCINES: PROSPECTS AND CONCERNS. Crit. Rev. Oral Biol. Med. 13: 335-349 [Abstract] [Full Text]  
• Jespersgaard, C., Zhang, P., Hajishengallis, G., Russell, M. W., Michalek, S. M. (2001). Effect of Attenuated Salmonella enterica Serovar Typhimurium Expressing a Streptococcus mutans Antigen on Secondary Responses to the Cloned Protein. Infect. Immun. 69: 6604-6611 [Abstract] [Full Text]  
• Smith, D. J., King, W. F., Barnes, L. A., Trantolo, D., Wise, D. L., Taubman, M. A. (2001). Facilitated Intranasal Induction of Mucosal and Systemic Immunity to Mutans Streptococcal Glucosyltransferase Peptide Vaccines. Infect. Immun. 69: 4767-4773 [Abstract] [Full Text]  
• Taubman, M. A., Holmberg, C. J., Smith, D. J. (2001). Diepitopic Construct of Functionally and Epitopically Complementary Peptides Enhances Immunogenicity, Reactivity with Glucosyltransferase, and Protection from Dental Caries. Infect. Immun. 69: 4210-4216 [Abstract] [Full Text]  
• Chia, J.-S., You, C.-M., Hu, C.-Y., Chiang, B.-L., Chen, J.-Y. (2001). Human T-Cell Responses to the Glucosyltransferases of Streptococcus mutans. CVI 8: 441-445 [Abstract] [Full Text]  
• Taubman, M. A., Smith, D. J., Holmberg, C. J., Eastcott, J. W. (2000). Coimmunization with Complementary Glucosyltransferase Peptides Results in Enhanced Immunogenicity and Protection against Dental Caries. Infect. Immun. 68: 2698-2703 [Abstract] [Full Text]  
• Jespersgaard, C., Hajishengallis, G., Huang, Y., Russell, M. W., Smith, D. J., Michalek, S. M. (1999). Protective Immunity against Streptococcus mutans Infection in Mice after Intranasal Immunization with the Glucan-Binding Region of S. mutans Glucosyltransferase. Infect. Immun. 67: 6543-6549 [Abstract] [Full Text]  
• Smith, D. J., Heschel, R. L., King, W. F., Taubman, M. A. (1999). Antibody to Glucosyltransferase Induced by Synthetic Peptides Associated with Catalytic Regions of alpha -Amylases. Infect. Immun. 67: 2638-2642 [Abstract] [Full Text]  
• Jespersgaard, C., Hajishengallis, G., Greenway, T. E., Smith, D. J., Russell, M. W., Michalek, S. M. (1999). Functional and Immunogenic Characterization of Two Cloned Regions of Streptococcus mutans Glucosyltransferase I. Infect. Immun. 67: 810-816 [Abstract] [Full Text]